HPV (human papillomavirus) is the primary cause of cervical cancer. It’s also linked to genital warts and some cancers in males.
Gardasil, the HPV vaccine available in Australia, protects against four key strains: HPV 6, 11, 16, and 18. These are responsible for the majority of cervical cancers and genital warts.
Eligibility:
- Girls and boys aged 12–13 (school program)
- Catch-up group: boys aged 14–15 (Years 9 in 2013–2014)
Others can access the vaccine privately at an additional cost. It’s most effective when given before sexual activity begins.
Administration: 3 doses over 6 months, typically given in the upper arm or thigh by your doctor.
Effectiveness: Clinical trials show the vaccine is nearly 100% effective against HPV types 16 and 18.
Safety: Side effects are generally mild—such as fever or redness at the injection site.
Ongoing need for screening: The vaccine does not protect against all cancer-causing HPV strains. Cervical screening remains essential for all sexually active women, even if vaccinated.
Vaccination for boys: Recommended as part of the school program to prevent HPV-related conditions.
Sexually active individuals: May still benefit, but protection only applies to types not already contracted.
Can’t afford the vaccine? Routine cervical screening remains a vital protective measure.
Other Women’s Health Related Links